Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Patent 10787501 was granted and assigned to Regeneron Pharmaceuticals on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 3 Jul, 2024

"update inverses"

Golden AI

edited on 3 Jul, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12024551 Coronavirus neutralizing humanized antibodies and uses thereof

Edits on 27 Jun, 2024

"update inverses"

Golden AI

edited on 27 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 12018054 Multivalent OspA polypeptides and methods and uses relating thereto

Edits on 6 Jun, 2024

"update inverses"

Golden AI

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11999777 Methods for treating or preventing SARS-CoV-2 infections and COVID-19 with anti-SARS-CoV-2 spike glycoprotein antibodies

Edits on 30 May, 2024

"update inverses"

Golden AI

edited on 30 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11993644 Antigen binding molecules targeting SARS-CoV-2

Edits on 23 May, 2024

"update inverses"

Golden AI

edited on 23 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11987796 Interferon production using short RNA duplexes

"update inverses"

Golden AI

edited on 22 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11987616 Antigen binding molecules targeting SARS-CoV-2

Edits on 15 May, 2024

"update inverses"

Golden AI

edited on 15 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11981725 Antigen binding molecules targeting SARS-CoV-2

Edits on 12 Mar, 2024

"update inverses"

Golden AI

edited on 12 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11919945 Neutralizing anti-SARS-CoV-2 antibodies

Edits on 19 Jan, 2024

"update inverses"

Golden AI

edited on 19 Jan, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11872279 SARS-CoV-2 antigens and uses thereof

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11834493 Antibody cocktail against SARS-CoV-2 spike protein

Edits on 2 Nov, 2023

"update inverses"

Golden AI

edited on 2 Nov, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11801238 Anti-viral activity of VPS34 inhibitors

Edits on 5 Jul, 2023

"update inverses"

Golden AI

edited on 5 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11693011 Neutralizing antibody immunoassays

Edits on 20 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 20 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=107875010

Edits on 28 Apr, 2023

"Entity importer update"

Golden AI

edited on 28 Apr, 2023

Infobox

Is a

Patent

Patent Applicant

Regeneron Pharmaceuticals

Current Assignee

Regeneron Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107875010

Date of Patent

September 29, 2020

Patent Application Number

169126780

Date Filed

June 25, 2020

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=107875010

Patent Citations Received

‌

US Patent 10954289 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

‌

US Patent 10975139 Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

‌

US Patent 11365239 Anti-SARS-COV-2 antibodies and uses thereof

‌

US Patent 11440952 Compositions for preventing or treating viral and other microbial infections

‌

US Patent 11479599 Antibodies against SARS-CoV-2 and methods of using the same

‌

US Patent 11623949 Anti-spike glycoprotein antibodies and the therapeutic use thereof

Patent Primary Examiner

‌

Benjamin P Blumel

Edits on 12 Apr, 2023

"update inverses"

Golden AI

edited on 12 Apr, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11623949 Anti-spike glycoprotein antibodies and the therapeutic use thereof

Edits on 6 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 6 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 10954289 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Edits on 22 Mar, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 22 Mar, 2023

Infobox

Patent Citations Received

‌

US Patent 11365239 Anti-SARS-COV-2 antibodies and uses thereof

Edits on 28 Oct, 2022

"update inverses"

Golden AI

edited on 28 Oct, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11479599 Antibodies against SARS-CoV-2 and methods of using the same

Edits on 26 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 26 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 10975139 Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments

"update citations for inverse infoboxes"

Golden AI

edited on 26 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 11440952 Compositions for preventing or treating viral and other microbial infections

Find more entities like US Patent 10787501 Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.